By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Castle Biosciences 

Houston  Texas    U.S.A.
Phone: n/a Fax: n/a



Company News
Results Of New Study With Castle Biosciences’ Skin Melanoma Gene Expression Test Published In Current Medical Research And Opinion 7/11/2016 8:48:22 AM
ASCO2016: Castle Biosciences Announces Clinical Results Of Melanoma Gene Expression Test In 334-Patient Performance Cohort Study At ASCO 2016 6/6/2016 8:22:11 AM
Castle Biosciences Announces New Clinical Data Presentations At ASCO 2016 Underscoring The Accuracy And Clinical Utility Of Gene Expression Profile Test For Cutaneous Melanoma 5/19/2016 12:22:54 PM
Castle Biosciences Announces The Appointment Of Bernhard E. Spiess As Chief Operating Officer 5/9/2016 11:03:04 AM
Independent Study Verifies The Performance Of Castle Biosciences’ Cutaneous Melanoma Gene Expression Profile Test For Predicting Risk Of Metastasis 5/2/2016 8:49:07 AM
Castle Biosciences Expands Credit Facility From Silicon Valley Bank 3/14/2016 7:56:48 AM
Castle Biosciences To Present At The 27th Annual Piper Jaffray Healthcare Conference 11/25/2015 8:11:34 AM
Study Shows Castle Biosciences’ DecisionDx-UM Is Highly Effective At Predicting Metastatic Risk In Patients With Eye Cancer 11/16/2015 10:38:33 AM
Castle Biosciences To Present At The Canaccord Genuity 2015 Medical Technology & Diagnostics Forum 11/13/2015 11:29:54 AM
Castle Biosciences Announces The Appointment Of Federico Monzon, M.D., FCAP As Chief Medical Officer 11/3/2015 11:19:07 AM